股票 › SYRE
斯派尔治疗 SYRE
美股市值排名 #1451
$103.86 +$7.27 (+7.53%)
休市 · Nov 7, 5:50 am ET · 最新盘后价 $103.00 -0.83%
开盘$98.35
昨收$96.59
当日区间$97.29 – $104.30
成交量1.64M
市值$9.86B
市盈率（TTM）–
股息率–
SYRE 相关新闻
匹配 Spyre Therapeutics 或代码 SYRE 的头条新闻，按最新排序。
- Jefferies Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $126 正面
- Leerink Partners Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $128 正面
- LifeSci Capital Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $116
- Wedbush Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $123
- JonesTrading Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $121
- LifeSci Capital Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $128 正面
- Wedbush Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $130 正面
- A Quick Look at Today's Ratings for Spyre Therapeutics(SYRE.US), With a Forecast Between $116 to $130
- Guggenheim Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $130
- A Quick Look at Today's Ratings for Spyre Therapeutics(SYRE.US), With a Forecast Between $115 to $127
- LifeSci Capital Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $129
- Stifel Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $123
- JonesTrading Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $140 正面
- BTIG Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $132 正面
- LifeSci Capital Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Raises Target Price to $129 正面
暂无评论——快来第一个聊聊 SYRE。
登录后参与讨论。